Equities

Genus PLC

GNS:LSE

Genus PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)1,894.00
  • Today's Change34.00 / 1.83%
  • Shares traded94.53k
  • 1 Year change-26.25%
  • Beta0.3122
Data delayed at least 20 minutes, as of May 15 2024 16:37 BST.
More ▼

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of GBP
(except for per share items)
Fiscal data as of Jun 30 2023202320222021
REVENUE AND GROSS PROFIT
Total revenue690593574
OPERATING EXPENSES
Cost of revenue total------
Selling, general and admin. expenses, total6.003.707.70
Depreciation/amortization7.708.30--
Unusual expense(income)207.4014
Other operating expenses, total615525505
Total operating expense649544527
Operating income414948
Other, net1.90(0.5)(0.9)
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes394856
Provision for income taxes7.60129.00
Net income after taxes323747
Minority interest1.504.200.50
Net income before extra. Items334147
Total extraordinary items------
Net income334147
Inc.avail. to common excl. extra. Items334147
Inc.avail. to common incl. extra. Items334147
EPS RECONCILIATION
Basic/primary weighted average shares666565
Basic/primary eps excl. extra items0.510.630.73
Basic/primary eps incl. extra items0.510.630.73
Dilution adjustment------
Diluted weighted average shares666566
Diluted eps excl. extra items0.500.630.72
Diluted eps incl. extra items0.500.630.72
COMMON STOCK DIVIDENDS
DPS - common stock primary issue0.320.320.32
Gross dividend - common stock21--22
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental156.104.50
SUPPLEMENTAL INCOME
Depreciation, supplemental302624
Total special items207.4014
NORMALISED INCOME
Normalized income before taxes605670
Effect of special items on income taxes3.941.792.27
Income tax excluding impact of special items121311
Normalized income after tax484259
Normalized income avail. to common504759
Basic normalized EPS0.760.710.91
Diluted normalized EPS0.750.710.90
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.